Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kian Fan Chung

Showing results (1-10 of 586) with videos related to

Pageof 59
Sort By:
Lancet (London, England)|May 1, 2016
Dupilumab: a potential new treatment for severe asthmaKian Fan Chung
American Journal of Respiratory and Critical Care Medicine|February 22, 2019
Predicting Response to Triamcinolone in Severe Asthma by Machine Learning. Solving the EnigmaKian Fan Chung
The Lancet. Respiratory Medicine|November 13, 2018
2-year safety and efficacy results for benralizumabKian Fan Chung
Pulmonary Pharmacology & Therapeutics|February 21, 2017
Advances in mechanisms and management of chronic cough: The Ninth London International Cough Symposium 2016Kian Fan Chung
Lung|October 3, 2007
Currently available cough suppressants for chronic coughKian Fan Chung
The Lancet. Respiratory Medicine|May 26, 2018
Tralokinumab unsuccessful for management of severe, uncontrolled asthmaKian Fan Chung
Pulmonary Pharmacology & Therapeutics|October 27, 2015
The Eighth 2014 International London Cough SymposiumKian Fan Chung
Current Opinion in Allergy and Clinical Immunology|May 15, 2023
Type-2-low severe asthma endotypes for new treatments: the new asthma frontierKian Fan Chung
The Lancet. Respiratory Medicine|February 16, 2015
Tiotropium as an add-on therapy in patients with symptomatic asthmaKian Fan Chung
The Lancet. Respiratory Medicine|January 28, 2014
New treatments for severe treatment-resistant asthma: targeting the right patientKian Fan Chung
Pageof 59

Showing results (1-10 of 586) with videos related to

Sort By:
Pageof 59
Lancet (London, England)|May 1, 2016
Dupilumab: a potential new treatment for severe asthmaKian Fan Chung
American Journal of Respiratory and Critical Care Medicine|February 22, 2019
Predicting Response to Triamcinolone in Severe Asthma by Machine Learning. Solving the EnigmaKian Fan Chung
The Lancet. Respiratory Medicine|November 13, 2018
2-year safety and efficacy results for benralizumabKian Fan Chung
Pulmonary Pharmacology & Therapeutics|February 21, 2017
Advances in mechanisms and management of chronic cough: The Ninth London International Cough Symposium 2016Kian Fan Chung
Lung|October 3, 2007
Currently available cough suppressants for chronic coughKian Fan Chung
The Lancet. Respiratory Medicine|May 26, 2018
Tralokinumab unsuccessful for management of severe, uncontrolled asthmaKian Fan Chung
Pulmonary Pharmacology & Therapeutics|October 27, 2015
The Eighth 2014 International London Cough SymposiumKian Fan Chung
Current Opinion in Allergy and Clinical Immunology|May 15, 2023
Type-2-low severe asthma endotypes for new treatments: the new asthma frontierKian Fan Chung
The Lancet. Respiratory Medicine|February 16, 2015
Tiotropium as an add-on therapy in patients with symptomatic asthmaKian Fan Chung
The Lancet. Respiratory Medicine|January 28, 2014
New treatments for severe treatment-resistant asthma: targeting the right patientKian Fan Chung
Pageof 59